#Leadership #Kenya #ACE Research #Victorine Owira #Kisumu

ACE Research Welcomes New Leadership

In a significant move for the clinical research landscape, ACE Research has announced the appointment of Victorine Owira as its new Chief Executive Officer, effective April 2025. This strategic shift comes as previous CEO and co-founder Victoria Tifft steps into the role of Strategic Advisor for the organization, paving the way for a new chapter in ACE Research's trajectory.

Victoria Tifft has been pivotal in establishing ACE Research as a renowned leader in the clinical research field. Her unwavering leadership and vision have laid a solid foundation, and the organization expresses gratitude for her continued involvement even as she transitions to a guidance role. Tifft remarked on Owira's appointment, stating, "We are thrilled to welcome Victorine Owira as our new CEO. Her strategic vision and dedication to scientific integrity align perfectly with ACE Research's commitment to improve health outcomes through high-quality research."

Victorine Owira arrives at this noteworthy position with a robust background that spans over 20 years in clinical research. Her previous role as the Director of Clinical Operations at ACE Research showcases her capability, where she managed teams across 37 countries throughout Africa and the United States. Owira's extensive expertise, coupled with her enthusiasm for clinical excellence, positions her as the ideal leader to navigate ACE Research's next phase of innovation and impact.

Under her leadership, ACE Research aims to strengthen its position in the global clinical research landscape. Owira’s notable track record of success is expected to contribute greatly to the company's mission of advancing healthcare solutions through rigorous research methodologies.

With her at the helm, ACE Research is poised to continue pushing the boundaries of clinical research, driving innovations that promise to enhance human health outcomes. The organization is excited about the prospect of expanding its global reach and influence in the clinical research arena under her stewardship.

In conclusion, Victorine Owira's appointment marks an exciting new era for ACE Research. The transition in leadership not only honors the legacy of Tifft but also ignites a promising future filled with potential breakthroughs in healthcare research. As ACE Research embarks on this new journey, all eyes will be on their initiatives and advancements that could shape the future of clinical trials worldwide.